Department of Health Sciences, University of Leicester, Leicester, UK.
Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Psychooncology. 2018 Jun;27(6):1559-1564. doi: 10.1002/pon.4694. Epub 2018 Apr 16.
Primary human papillomavirus (HPV) cervical screening is due to be implemented in England within the next 2 years; however, the acceptability of HPV testing as the primary screening test is unclear. This study explores women's awareness and attitudes toward HPV testing/screening.
Qualitative interviews (semistructured and focus group) were conducted with 46 women (aged 25-65 years) from community and secondary care settings. Data were analyzed by using the inductive-framework method.
Women were unaware that cervical screening currently includes HPV testing and lacked HPV-related knowledge. Emotions of shock, fear, and anxiety were reported upon receiving a positive HPV result. For women in long-term relationships, the realization that HPV is a sexually transmitted infection was seen as a barrier to primary HPV testing. Knowledge that HPV testing is a screening test to prevent cervical cancer did not change their attitudes. Women debated the need for continued screening following a negative result. Women feared judgment by the community if they participated with primary HPV screening because they were being tested for a sexually transmitted infection, with the possible attendant perception that they had adopted a high-risk lifestyle in comparison to nonattenders.
The acceptability of HPV testing may be a limiting factor in encouraging participation with screening in the future.
原发性人乳头瘤病毒(HPV)宫颈筛查将在未来 2 年内于英国实施;然而,HPV 检测作为初级筛查试验的可接受性尚不清楚。本研究探讨了女性对 HPV 检测/筛查的认知和态度。
采用半结构式和焦点小组访谈法,对来自社区和二级保健机构的 46 名年龄在 25-65 岁的女性进行了定性访谈。采用归纳框架法进行数据分析。
女性不知道目前的宫颈筛查包括 HPV 检测,并且缺乏 HPV 相关知识。得知 HPV 检测结果呈阳性后,她们感到震惊、恐惧和焦虑。对于长期处于性关系中的女性来说,意识到 HPV 是一种性传播感染,这被视为对原发性 HPV 检测的一个障碍。知道 HPV 检测是一种预防宫颈癌的筛查试验并没有改变她们的态度。女性对阴性结果后的继续筛查的必要性存在争议。如果女性参与原发性 HPV 筛查,她们担心会受到社区的评判,因为她们是为了筛查性传播感染而接受检测,可能会被认为与未参与者相比,她们采取了高风险的生活方式。
HPV 检测的可接受性可能是未来鼓励参与筛查的一个限制因素。